HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 31 filers reported holding HEPION PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $36,898 | +269.0% | 47,524 | +41.0% | 0.00% | – |
| Q4 2022 | $10,000 | -37.5% | 33,701 | +8.4% | 0.00% | – |
| Q3 2022 | $16,000 | +14.3% | 31,093 | +25.5% | 0.00% | – |
| Q2 2022 | $14,000 | -51.7% | 24,766 | +7.7% | 0.00% | – |
| Q1 2022 | $29,000 | +11.5% | 22,989 | -1.7% | 0.00% | – |
| Q4 2021 | $26,000 | +4.0% | 23,389 | +40.9% | 0.00% | – |
| Q3 2021 | $25,000 | -28.6% | 16,604 | -6.5% | 0.00% | – |
| Q2 2021 | $35,000 | +105.9% | 17,751 | +94.9% | 0.00% | – |
| Q1 2021 | $17,000 | +112.5% | 9,109 | +153.4% | 0.00% | – |
| Q4 2020 | $8,000 | 0.0% | 3,595 | +43.7% | 0.00% | – |
| Q3 2020 | $8,000 | +166.7% | 2,501 | +149.9% | 0.00% | – |
| Q2 2020 | $3,000 | – | 1,001 | +100000.0% | 0.00% | – |
| Q1 2020 | $0 | – | 1 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 306,338 | $564,000 | 0.11% |
| PVG ASSET MANAGEMENT CORP | 14,140 | $26,018,000 | 0.08% |
| GSA CAPITAL PARTNERS LLP | 160,775 | $296,000 | 0.05% |
| Virtu Financial LLC | 179,030 | $329,000 | 0.02% |
| Allen Capital Group, LLC | 23,685 | $44,000 | 0.01% |
| McAdam, LLC | 36,641 | $67,000 | 0.01% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 10,000 | $18,000 | 0.01% |
| ZEKE CAPITAL ADVISORS, LLC | 50,000 | $92,000 | 0.01% |
| JGP Wealth Management, LLC | 15,000 | $28,000 | 0.01% |
| Onex Canada Asset Management Inc. | 40,000 | $74,000 | 0.00% |